Intrinsic Value of S&P & Nasdaq Contact Us

BeiGene, Ltd. BGNE NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
73/100
5/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$258.00
+39.7%
SharesGrow 7-Criteria Score All 7 criteria scored · income-related highlighted on this page

BeiGene, Ltd. (BGNE) has shown exceptional revenue growth over the past 3 years, expanding from $1.4B to $5.3B (average +56.3%/yr). Net income reached $287M, reflecting exceptional earnings expansion at +75.8%/yr on average. The net profit margin is 5.4%, which is moderate. the company was profitable in 1 out of the last 4 years tracked. The gross margin is 87.5% (high), with a +123.6pp trend over the period. With a $20B market cap and MOAT composite score of 80/100, the company has a strong competitive position.

Criteria proven by this page:

  • GROWTH (100/100, Pass) — proving strong growth momentum
  • PAST (25/100, Fail) — the company has frequently reported losses. Looking at the full 13-year history, the company was profitable in 1 of 13 years — a mixed long-term record
  • INCOME (45/100, Partial) — the company is profitable but margin is below 15%
  • MOAT (80/100, Pass) — strong gross margins and market scale prove a durable competitive advantage

Overall SharesGrow Score: 73/100 with 5/7 criteria passed.

73/100
SG Score
View full scorecard →
VALUE
94/100
Price-to-Earnings & upside
→ IV page
FUTURE
85/100
Analyst consensus
→ Forecast
PAST
25/100
1/4 yrs profit
EPS $32.89
Proven by this page
HEALTH
83/100
Debt-to-Equity & liquidity
→ Health
MOAT
80/100
Score: 80/100
GM 87.5% (+123.6pp)
Proven by this page
GROWTH
100/100
Rev +56.3%/yr
NI +75.8%/yr
Proven by this page
~
INCOME
45/100
Margin 5.4%
$5.3B
Proven by this page
BeiGene, Ltd. Earnings and Revenue History
Revenue
Earnings & Profit Margin
Metric TTM FY2025 FY2024 FY2023 FY2022
Revenue $5.34B$5.34B$3.81B$2.46B$1.42B
Gross Profit $4.67B$4.67B$3.22B$2.08B$-511.06M
Gross Margin 87.5%87.5%84.4%84.5%-36.1%
Operating Income $447.14M$447.14M$-568.2M$-1.21B$-1.79B
Net Income $286.93M$286.93M$-644.79M$-881.71M$-2B
Net Margin 5.4%5.4%-16.9%-35.9%-141.5%
EPS (Diluted) $32.90$32.89$-6.11$-8.45$-19.37
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message